Be The First To
To heck with verbs, Seattle Genetics is conjugating antibodies and drugs to fight cancer. The company's technologies use genetically engineered monoclonal antibodies (MAbs, or single source proteins) to trigger cell death in some cancers, but when they can't do it alone, Seattle Genetics pairs them up with drugs using its Antibody-Drug Conjugate (ADC) technology for a one-two punch. Its first product, Adcetris, gained FDA approval in 2011 for treatment of lymphoma in specific patient categories. With partner Millennium Pharmaceuticals, the company is working to expand...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Employees say it's “OK” 13 ratings
56% of the CEO 9 ratings
Clay B. Siegall
President and CEO
No Offer – Interviewed in Seattle, WA (US) Dec 2013 – Reviewed Mar 05, 2014
Interview Details It is the worst interview i have attended a hr has called me regarding the position and we had discussion for 25 min and then they have not contacted me or updated me regarding the position even when i have been asking them continuously .It is the worst company even if they would have offered a… – Full Interview
no difficult questions – Answer Question
Let us know if we're missing any workplace or industry recognition –